The National Institute of Standards and Technology’s Artificial Intelligence Safety Institute is seeking information on the development of chemical and biology-focused artificial intelligence models.
Team to develop and validate computational models trained on data from organoids and advanced human model systems that will improve drug safety and reduce reliance on animal testing NEW YORK, Dec. 8, ...
CAMBRIDGE, England--(BUSINESS WIRE)--bit.bio, the company coding human cells for novel cures, and the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London today announce ...
Tuesday, French drugmaker Sanofi SA (NASDAQ:SNY) announced its collaboration with OpenAI and Formation Bio to accelerate drug development projects. Also Read: Drugmaker Sanofi’s Strong Dupixent And ...
CompagOS has produced biologically reproducible Bon3OID™ bone models using 3D bioprinting. Find out more in the interview!